Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2021 Earnings Conference Call February 23, 2022 5:00 PM ET Company Participants Christine Cassiano - Chief Communications Officer David Chang - President & Chief Executive Officer Rafael Amado - Executive Vice President, Research & Development & Chief Medical Officer Alison Moore - Chief Technical Officer Eric Schmidt - Chief Financial Officer Conference Call Participants Michael Yee - Jefferies Salveen Richter - Goldman Sachs Tyler Van Buren - Cowen Mark Breiden ...